---
title: "ICCM: First FDA-cleared minimally invasive cryoablation device for breast cancer, driving global growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292679809.md"
description: "ProSense is the only FDA-authorized minimally invasive cryoablation device for breast cancer, offering rapid recovery, superior cosmetic outcomes, and strong clinical validation. With global regulatory approvals, robust IP, and strategic partnerships, the platform is poised for significant growth and expansion into additional cancer indications.Original document: IceCure Medical Ltd. [ICCM] Slides Release — Jul. 14 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-14T21:57:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292679809.md)
  - [en](https://longbridge.com/en/news/292679809.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292679809.md)
generator: "portal-rs"
---

# ICCM: First FDA-cleared minimally invasive cryoablation device for breast cancer, driving global growth

ProSense is the only FDA-authorized minimally invasive cryoablation device for breast cancer, offering rapid recovery, superior cosmetic outcomes, and strong clinical validation. With global regulatory approvals, robust IP, and strategic partnerships, the platform is poised for significant growth and expansion into additional cancer indications.

Original document: IceCure Medical Ltd. \[ICCM\] Slides Release — Jul. 14 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ICCM.US](https://longbridge.com/en/quote/ICCM.US.md)

## Related News & Research

- [IceCure says West Cancer Center begins enrollment for ChoICE breast cancer cryoablation study](https://longbridge.com/en/news/296489702.md)
- [08:10 ETWest Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation](https://longbridge.com/en/news/296488705.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [09:10 ETIceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation](https://longbridge.com/en/news/295805121.md)
- [IceCure highlights 5-year ICE3 breast cancer trial showing 3.1% recurrence rate after cryoablation](https://longbridge.com/en/news/295804964.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**